Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer

BACKGROUND: We conducted a phase I trial to determine the safety of systemic chemotherapy prior to abdominopelvic robotic stereotactic ablative radiotherapy (SABR) in women with persistent or recurrent gynecologic cancers. METHODS: Patients were assigned to dose-finding cohorts of day 1 carboplatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunos, Charles A., Sherertz, Tracy M., Mislmani, Mazen, Ellis, Rodney J., Lo, Simon S., Waggoner, Steven E., Zanotti, Kristine M., Herrmann, Karin, Debernardo, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456851/
https://www.ncbi.nlm.nih.gov/pubmed/26097831
http://dx.doi.org/10.3389/fonc.2015.00126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456851/
https://www.ncbi.nlm.nih.gov/pubmed/26097831
http://dx.doi.org/10.3389/fonc.2015.00126

Ejemplares similares